Home Latest Articles
Latest Articles
  • Siyuan LI, Ruiping WANG
    World Clinical Drug. 2024, 45(5): 521-526.
    Objective

    To evaluate the reliability and validity of the application of Shared Decision Making Questionnaire for Phyxicians Chinese version of Shared Decision-making Questionnaire in aesthetic medicine.

    Methods

    The Chinese version of Shared Decision-making Questionnaire was used to survey 50 medical aesthetic practitioners in public and private medical institutions in Shanghai, and a total of 50 valid questionnaires were collected. SPSS22.0 software was used for statistical analysis. Spearman-Brown formula was used to calculate split-half reliability, Cronbach's α coefficient was used to evaluate the internal consistency reliability of the questionnaire. Factor analysis method was used to evaluate the structural validity.

    Results

    Among the 50 medical beauty practitioners, 66% of which were female, and 92% worked in public medical institutions. The Chinese version of Shared Decision-Making Questionnaire included three scales: Shared decision-making process scale (T1), Shared decision-making barriers scale (T2) and shared decision-making facilitators scale (T3). The split-half reliability coefficients of the three scales were 0.86, 0.91 and 0.84, respectively. Cronbach's α coefficients of the three scales were 0.92, 0.93 and 0.87, respectively. The cumulative variance contribution rates of the three scales were 63.16%, 65.81% and 57.01%, respectively.

    Conclusion

    The Chinese version of Shared Decision-making Questionnaire developed by the project team has good reliability and validity, which can be applied to evaluate the development of shared decision-making in the field of medical aesthetics, and can also be a tool for doctors to improve compliance of patients with medication and improve the effectiveness of drug treatment.

  • Yuan LIU
    World Clinical Drug. 2024, 45(5): 527-529.
  • Xin BAI, Minyu LIU
    World Clinical Drug. 2024, 45(5): 530-536.

    Nonalcoholic fatty liver disease (NAFLD), as a widespread chronic hepatic disease, is caused by the accumulation of hepatocellular triglyceride, instigating immunological engagement and accompanied by histopathological alterations. NAFLD's a progressive ailment, and the inflammatory response is the driving force in the progression of NAFLD, with various triggers involving metabolic damage often leading to the activation of different immunocytes. The specific drug for NAFLD remains deficient. Stem cell-derived exosomes, representing an innovative therapeutic modality with minimized immunogenicity, are used to suppress the immune reactions in tissues. This article aimed to explore the pathogenesis of NAFLD and the importance of liver in human immunity, discuss the role of different immunocytes in the pathogenesis and progression of NAFLD, deeply understand the pathogenesis of immunocytes involved in NAFLD, summarize the current immunotherapy, and to provide theoretical support for the design of new immunotherapy.

  • Nan LI, Jiyong MA
    World Clinical Drug. 2024, 45(5): 537-541.

    B-cell lymphoma-2 cell death interaction regulator (Bim) is an important component of the B-cell lymphoma (Bcl)-2 family, and is the only protein in the Bcl-2 apoptosis protein family with a BH3 homologous domain. Bim can induce apoptosis by binding to apoptotic members in Bcl-2 through BH3 domain or directly activating pro-apoptotic molecules. The low expression of Bim protein is closely related to the development, prognosis and anti-tumor drug resistance of various tumors. Regulation of Bim protein expression has become a research hotspot. This article reviewed the research progress of Bim protein in antitumor.

  • Xianhao WANG, Hao YANG, Yuqing ZHANG, Ming WANG, Qi ZHAO, Xijie WANG
    World Clinical Drug. 2024, 45(5): 542-548.

    Chemotherapeutic drugs are one of the common methods for clinical treatment of tumor diseases. However, chemotherapy-induced peripheral neurotoxicity (CIPN) has become a major factor affecting patients' daily life and work. Mitochondrial damage is one of the main causes of the formation and development of CIPN. When mitochondria are damaged, mitochondrial-derived damage-associated molecular patterns (mtDAMPs) are released into the extracellular environment, which can induce inflammatory responses. Therefore, it is of great significance to explore the mechanism of mtDAMPs in CIPN. However, although there is a large amount of data describing the widespread effects of mtDAMPs on CIPN, the exact mechanism remains unelucidated. Therefore, the mechanism of mtDAMPs induced CIPN and its potential therapeutic agents were reviewed in this paper to provide reference for clinical and non-clinical studies.

  • Xuelan ZHANG, Xiaomeng YE, Jian ZHAO, Jing MENG
    World Clinical Drug. 2024, 45(5): 549-554.

    There are many eosinophilia-related diseases, with different etiologies and different therapeutic programs. The first-line treatment for non-infectious and non-tumor-related eosinophilia-related diseases is mostly glucocorticoids, which can be combined with immunosuppressive agents according to the severity of the disease. Mepolizumab is a human anti-interleukin-5 monoclonal antibody which has been approved by the FDA for second-line treatment for chronic sinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome. This article reviewed the research progress of mepolizumab in the application of eosinophilia-related diseases except bronchial asthma.

  • Xiaodong ZHAO, Yaqun ZHANG, Yong MENG, Yani XIONG, Hua LI
    World Clinical Drug. 2024, 45(5): 555-560.

    Glaucoma is an irreversible neurodegenerative blinding eye disease that seriously jeopardizes patients' physical and mental health and quality of life. Glaucoma is often accompanied by headache and other symptoms, and the visual findings associated with migraine are similar to those of glaucoma, with vascular risk factors present in pathophysiology. Whether migraine is only a concomitant condition in patients with glaucoma or is a risk factor for glaucoma remains controversial. This article reviewed the epidemiology and pathophysiologic correlations and clinical similarities between glaucoma and migraine, in order to better elucidate the clinical correlation between glaucoma and migraine, to provide a reference for subsequent studies.

  • Tiantian ZHANG, Hua YE, Xuyu CHAI
    World Clinical Drug. 2024, 45(5): 561-566.

    Endoscopic submucosal dissection (ESD) is a minimally invasive operation to completely resect the overall mucosal lesions with the assistance of an endoscopy, which is often used for early esophageal cancer and precancerous lesions. However, the mucosal defect caused by ESD is very easy to cause esophageal stenosis, which seriously affects the quality of life of patients. At present, many drugs have been tried for the prevention of ESD postoperative stenosis, and the most successful application is oral and local injection of glucocorticoids. Based on the causes and mechanisms of esophageal stenosis, this article reviewed the preventive drugs especially glucocorticoids for ESD postoperative stenosis.

  • Ruiping WANG, Bin LI
    World Clinical Drug. 2024, 45(4): 349-357.

    In recent years, clinical research on skin diseases based on clinical diagnosis and treatment practices has been increasingly valued and recognized by dermatology medical and scientific researchers. How to propose scientific questions based on clinical practice in dermatology, and how to solve clinical problems through standardized clinical research design are the driving forces for the continuous improvement of clinical diagnosis and treatment level of dermatology. This article took the selection of clinical research topics as the starting point, proposed the sources of clinical research topics for skin diseases, pointed out the guiding principles of representativeness, authenticity, comparability and significance that should be followed in research design, and elaborated the design norms and key points of clinical research on skin diseases from the aspects of patient recruitment, sample size, control setting, randomized grouping, blinding, intervention implementation, efficacy evaluation, quality control, and statistical analysis involved in the selection of clinical research topics, based on the principles of PICO (patient, intervention, control and outcome) and consolidated standards of reporting trials. To provide reference for the design of clinical research in dermatology.

  • Na NI, Shan JIANG, Jingyi FENG, Jiaxin LIU, Junlong WANG, Guiliang CHEN
    World Clinical Drug. 2024, 45(4): 358-363.

    As a special biological product, blood products should not only comply with relevant laws and regulations of clinical research, but also need to be considered in the aspects of protocol design, project management, data management, and statistical analysis. This article mainly analyzed the current situation, key points of protocol design, and project management from the perspective of clinical research on blood products, to provide some research ideas for the clinical research of blood products, expand product applications, and improve the efficiency and quality of product clinical research.

News